Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea · Delayed Price · Currency is KRW 72,400
-3,600 (-4.74%)
At close: Feb 6, 2026
Next Biomedical Market Cap
Next Biomedical has a market cap or net worth of 593.96 billion as of February 6, 2026. Its market cap has increased by 55.61% in one year.
Market Cap
593.96B
Enterprise Value
574.79B
Revenue
14.90B
Ranking
n/a
PE Ratio
n/a
Stock Price
72,400.00
Market Cap Chart
Since August 20, 2024, Next Biomedical's market cap has increased from 189.79B to 593.96B, an increase of 212.96%. That is a compound annual growth rate of 117.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 593.96B | -19.02% |
| Dec 30, 2025 | 733.43B | 121.21% |
| Dec 30, 2024 | 331.55B | 74.69% |
| Aug 20, 2024 | 189.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MEDIANA Co.,Ltd | 528.63B |
| ASTERASYS Co.,Ltd | 500.72B |
| L&K Biomed | 304.44B |
| Vuno Inc. | 268.27B |
| DRTECH | 152.93B |
| SELVAS Healthcare | 129.87B |
| Noul Co.,Ltd. | 89.14B |
| Remed | 88.09B |